Kynam Capital Management »

Ironwood Pharmaceuticals shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 1.6M 8.71

More positions owned by Kynam Capital Management

Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Dynavax Technologies Corp Com New (DVAX)
Vaxcyte (PCVX)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Liquidia Corporation Com New (LQDA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Wave Life Sciences SHS (WVE)
Travere Therapeutics (TVTX)
Corcept Therapeutics Incorporated Put Option (CORT)

View all positions for Kynam Capital Management

Top funds holding Ironwood Pharmaceuticals

UBS Group
BlackRock
Vanguard Group
Sarissa Capital Management
Pacer Advisors
LSV Asset Management
Armistice Capital
Jacobs Levy Equity Management
Braidwell
Geode Capital Management
Man Group
Morgan Stanley
Nuveen Asset Management
Kynam Capital Management
Citadel Advisors

View all funds holding Ironwood Pharmaceuticals